Cargando…
Anti‐C1q autoantibodies from systemic lupus erythematosus patients enhance CD40–CD154‐mediated inflammation in peripheral blood mononuclear cells in vitro
OBJECTIVES: Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease with complex pathogenic mechanisms. Complement C1q has been shown to play a major role in SLE, and autoantibodies against C1q (anti‐C1q) are strongly associated with SLE disease activity and severe lupus...
Autores principales: | Rabatscher, Pascal Alexander, Trendelenburg, Marten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345742/ https://www.ncbi.nlm.nih.gov/pubmed/35928801 http://dx.doi.org/10.1002/cti2.1408 |
Ejemplares similares
-
Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus
por: Kleer, Jessica S., et al.
Publicado: (2022) -
Autoantibodies against complement component C1q in systemic lupus erythematosus
por: Trendelenburg, Marten
Publicado: (2021) -
A Role for CD154, the CD40 Ligand, in Granulomatous Inflammation
por: Villeneuve, Julien, et al.
Publicado: (2017) -
CD154: An Immunoinflammatory Mediator in Systemic Lupus Erythematosus and Rheumatoid Arthritis
por: Alaaeddine, Nada, et al.
Publicado: (2012) -
Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus
por: Nehring, Josephine, et al.
Publicado: (2018)